The Role of Concomitant Nrf2 Targeting and Stem Cell Therapy in Cerebrovascular Disease

Despite the reality that a death from cerebrovascular accident occurs every 3.5 min in the United States, there are few therapeutic options which are typically limited to a narrow window of opportunity in time for damage mitigation and recovery. Novel therapies have targeted pathological processes s...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordon, Jonah, Lockard, Gavin, Monsour, Molly, Alayli, Adam, Borlongan, Cesario V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332234/
https://www.ncbi.nlm.nih.gov/pubmed/35892653
http://dx.doi.org/10.3390/antiox11081447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332234/
https://www.ncbi.nlm.nih.gov/pubmed/35892653
http://dx.doi.org/10.3390/antiox11081447

Ejemplares similares